Joon Lee
Stock Analyst at Truist Financial
(4.97)
# 85
Out of 4,969 analysts
517
Total ratings
59.5%
Success rate
37.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Reiterated: Hold | n/a | $2.74 | - | 22 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | n/a | $3.19 | - | 16 | Mar 17, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | n/a | $8.74 | - | 11 | Mar 13, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $700 | $330.55 | +111.77% | 29 | Mar 12, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $525 | $519.51 | +1.06% | 16 | Mar 11, 2026 | |
| ANAB AnaptysBio | Reiterated: Hold | $50 | $54.11 | -7.60% | 30 | Mar 9, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | n/a | $31.53 | - | 43 | Mar 5, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | n/a | $66.41 | - | 14 | Mar 3, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | n/a | $111.80 | - | 38 | Mar 2, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | n/a | $52.96 | - | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.87 | - | 29 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.48 | - | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.58 | - | 41 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.83 | - | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $245.87 | - | 26 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $216.58 | - | 37 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $76 | $13.61 | +458.41% | 29 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.00 | - | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.78 | - | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.01 | - | 24 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $990.54 | n/a | 38 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.21 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.89 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $65 | $8.40 | n/a | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4 | $4.44 | n/a | 4 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $16.30 | n/a | 1 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.43 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $76 | $44.93 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.92 | n/a | 1 | Aug 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $27.52 | n/a | 1 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.24 | n/a | 1 | Jul 28, 2014 |
Editas Medicine
Mar 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.74
Upside: -
Voyager Therapeutics
Mar 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.19
Upside: -
Solid Biosciences
Mar 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.74
Upside: -
Praxis Precision Medicines
Mar 12, 2026
Reiterated: Buy
Price Target: $700
Current: $330.55
Upside: +111.77%
Vertex Pharmaceuticals
Mar 11, 2026
Reiterated: Buy
Price Target: $525
Current: $519.51
Upside: +1.06%
AnaptysBio
Mar 9, 2026
Reiterated: Hold
Price Target: $50
Current: $54.11
Upside: -7.60%
Viking Therapeutics
Mar 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.53
Upside: -
BioMarin Pharmaceutical
Mar 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.41
Upside: -
Corcept Therapeutics
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $111.80
Upside: -
CRISPR Therapeutics AG
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $52.96
Upside: -
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.87
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.48
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.58
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $45.83
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $245.87
Upside: -
Feb 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $216.58
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $90 → $76
Current: $13.61
Upside: +458.41%
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $44.00
Upside: -
Nov 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.78
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.01
Upside: -
Aug 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $990.54
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: n/a
Current: $11.21
Upside: n/a
Nov 14, 2023
Reiterated: Buy
Price Target: $18
Current: $7.89
Upside: n/a
Jan 17, 2023
Reiterated: Buy
Price Target: $100 → $65
Current: $8.40
Upside: n/a
Dec 8, 2022
Reiterated: Hold
Price Target: $7 → $4
Current: $4.44
Upside: n/a
Aug 8, 2019
Reiterated: Buy
Price Target: $10
Current: $16.30
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $20
Current: $5.43
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $76
Current: $44.93
Upside: n/a
Aug 8, 2014
Reiterated: Buy
Price Target: n/a
Current: $20.92
Upside: n/a
Aug 7, 2014
Reiterated: Buy
Price Target: $33
Current: $27.52
Upside: n/a
Jul 28, 2014
Reiterated: Buy
Price Target: $14
Current: $1.24
Upside: n/a